Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3126197rdf:typepubmed:Citationlld:pubmed
pubmed-article:3126197lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3126197lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:3126197lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:3126197lifeskim:mentionsumls-concept:C1512795lld:lifeskim
pubmed-article:3126197lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:3126197pubmed:issue4lld:pubmed
pubmed-article:3126197pubmed:dateCreated1988-4-19lld:pubmed
pubmed-article:3126197pubmed:abstractTextBinding of chemoattractants to specific cell surface receptors on polymorphonuclear leukocytes (PMNs) initiates a series of biochemical responses leading to cellular activation. A critical early biochemical event in chemoattractant (CTX) receptor-mediated signal transduction is the phosphodiesteric cleavage of plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP2), with concomitant production of the calcium mobilizing inositol-1,4,5-trisphosphate (IP3) isomer, and the protein kinase C activator, 1,2-diacylglycerol (DAG). The following lines of experimental evidence collectively suggest that CTX receptors are coupled to phospholipase C via a guanine nucleotide binding (G) protein. Receptor-mediated hydrolysis of PIP2 in PMN plasma membrane preparations requires both fMet-Leu-Phe and GTP, and incubation of intact PMNs with pertussis toxin (which ADP ribosylates and inactivates some G proteins) eliminates the ability of fMet-Leu-Phe plus GTP to promote PIP2 breakdown in isolated plasma membranes. Studies with both PMN particulate fractions and with partially purified fMet-Leu-Phe receptor preparations indicate that guanine nucleotides regulate CTX receptor affinity. Finally, fMet-Leu-Phe stimulates high-affinity binding of GTP gamma S to PMN membranes as well as GTPase activity. A G alpha subunit has been identified in phagocyte membranes which is different from other G alpha subunits on the basis of molecular weight and differential sensitivity to ribosylation by bacterial toxins. Thus, a novel G protein may be involved in coupling CTX receptors to phospholipase C. Studies in intact and sonicated PMNs demonstrate that metabolism of 1,4,5-IP3 proceeds via two distinct pathways: 1) sequential dephosphorylation to 1,4-IP2, 4-IP1 and inositol, or 2) ATP-dependent conversion to inositol 1,3,4,5-tetrakisphosphate (IP4) followed by sequential dephosphorylation to 1,3,4-IP3, 3,4-IP2, 3-IP1 and inositol. Receptor-mediated hydrolysis of PIP2 occurs at ambient intracellular Ca2+ levels; but metabolism of 1,4,5-IP3 via the IP4 pathway requires elevated cytosolic Ca2+ levels associated with cellular activation. Thus, the two pathways for 1,4,5-IP3 metabolism may serve different metabolic functions. Additionally, inositol phosphate production appears to be controlled by protein kinase C, as phorbol myristate acetate (PMA) abrogates PIP2 hydrolysis by interfering with the ability of the activated G protein to stimulate phospholipase C. This implies a physiologic mechanism for terminating biologic responses via protein kinase C mediated feedback inhibition of PIP2 hydrolysis.lld:pubmed
pubmed-article:3126197pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:languageenglld:pubmed
pubmed-article:3126197pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:citationSubsetIMlld:pubmed
pubmed-article:3126197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3126197pubmed:statusMEDLINElld:pubmed
pubmed-article:3126197pubmed:monthDeclld:pubmed
pubmed-article:3126197pubmed:issn0730-2312lld:pubmed
pubmed-article:3126197pubmed:authorpubmed-author:SnydermanRRlld:pubmed
pubmed-article:3126197pubmed:authorpubmed-author:MurrayJ JJJlld:pubmed
pubmed-article:3126197pubmed:authorpubmed-author:UhingR JRJlld:pubmed
pubmed-article:3126197pubmed:authorpubmed-author:DillonS BSBlld:pubmed
pubmed-article:3126197pubmed:issnTypePrintlld:pubmed
pubmed-article:3126197pubmed:volume35lld:pubmed
pubmed-article:3126197pubmed:ownerNLMlld:pubmed
pubmed-article:3126197pubmed:authorsCompleteYlld:pubmed
pubmed-article:3126197pubmed:pagination345-59lld:pubmed
pubmed-article:3126197pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:meshHeadingpubmed-meshheading:3126197-...lld:pubmed
pubmed-article:3126197pubmed:year1987lld:pubmed
pubmed-article:3126197pubmed:articleTitleRegulation of inositol phospholipid and inositol phosphate metabolism in chemoattractant-activated human polymorphonuclear leukocytes.lld:pubmed
pubmed-article:3126197pubmed:affiliationHoward Hughes Medical Institute, Durham, North Carolina.lld:pubmed
pubmed-article:3126197pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3126197pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3126197pubmed:publicationTypeReviewlld:pubmed
pubmed-article:3126197pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3126197lld:pubmed